Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease.
The Journal of asthma : official journal of the Association for the Care of Asthma(2023)
摘要
Models representing transitions from all-nebulized to nebulizer-plus-MDI respiratory medications resulted in cost savings, largely from the reduction of labor cost of nebulizer administration with nebs-only treatment. Therefore, transitioning from nebs to MDIs can lead to cost savings and could allow greater opportunities for inhaler education.
更多查看译文
关键词
COPD,High-value care,asthma,metered dose inhalers,patient education,self-management
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要